Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.
Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.
复制标题
DOI:
10.1161/atvbaha.120.314609
复制
发表时间:
2020-11
期刊:
影响因子:
--
通讯作者:
Jensen MK
中科院分区:
文献类型:
--
作者:
Sacks FM;Liang L;Furtado JD;Cai T;Davidson WS;He Z;McClelland RL;Rimm EB;Jensen MK
HDL contains functional proteins that define single subspecies, each comprising 1 to 12% of the total HDL. We studied the differential association with coronary heart disease (CHD) of 15 such subspecies. We measured plasma apolipoprotein A1 (apoA1) concentrations of 15 protein-defined HDL subspecies in four US-based prospective studies. Among participants without CVD at baseline, 932 developed CHD during 10 to 25 years. They were matched 1:1 to controls who did not experience CHD. In each cohort, hazard ratios (HRs) for each subspecies were computed by conditional logistic regression, and combined by meta-analysis. Higher levels of HDL subspecies containing alpha-2 macroglobulin, complement C3, haptoglobin, or plasminogen were associated with higher relative risk compared to the HDL counterpart lacking the defining protein (HR range 0.96 to 1.11 per 1 SD increase vs. 0.73 to 0.81, respectively; p heterogeneity <0.05). In contrast, HDL containing apoC1 or apoE were associated with lower relative risk compared to the counterpart (HR 0.74, p=0.002 and 0.77, p=0.001, respectively). Several subspecies of HDL defined by single proteins that are involved in thrombosis, inflammation, immunity and lipid metabolism are found in small fractions of total HDL and are associated with higher relative risk of CHD compared to HDL that lacks the defining protein. In contrast, HDL containing apoC1 or apoE are robustly associated with lower risk. The balance between beneficial and harmful subspecies in a person’s HDL sample may determine the risk of CHD pertaining to HDL and paths to treatment.
影响因子:
4.5
作者:
Wang L;Sacks FM;Furtado JD;Ricks M;Courville AB;Sumner AE
通讯作者:
Sumner AE